Form 8-K - Current report:
SEC Accession No. 0001935979-25-000074
Filing Date
2025-08-15
Accepted
2025-08-15 17:22:45
Documents
15
Period of Report
2025-08-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20250815.htm   iXBRL 8-K 25208
2 EX-5.1 exhibit51maplesopinionandc.htm EX-5.1 33633
7 image_0a.jpg GRAPHIC 83636
  Complete submission text file 0001935979-25-000074.txt   292410

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20250815.xsd EX-101.SCH 2057
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20250815_def.xml EX-101.DEF 2862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20250815_lab.xml EX-101.LAB 23445
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20250815_pre.xml EX-101.PRE 14142
18 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20250815_htm.xml XML 2706
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 251225694
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)